{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:29:10Z","timestamp":1760243350973,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T00:00:00Z","timestamp":1413244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aim of this research is to develop a human\/murine chimeric Fab antibody which neutralizes the anthrax toxin, protective antigen (PA). The chimeric Fab was constructed using variable regions of murine anti-PA monoclonal antibody in combination with constant regions of human IgG. The chimeric PA6-Fab was expressed in E. coli. BL21 and evaluated by ELISA and co-immunoprecipitation- mass spectra. The potency of PA6-Fab to neutralize LeTx was examined in J774A.1 cell viability in vitro and in Fisher 344 rats in vivo. The PA6-Fab did not have domain similarity corresponding to the current anti PA mAbs, but specifically bound to anthrax PA at an affinity of 1.76 nM, and was able to neutralize LeTx in vitro and protected 56.9% cells at 20 \u03bcg\/mL against anthrax LeTx. One hundred \u03bcg PA6-Fab could neutralize 300 \u03bcg LeTx in vivo. The PA6-Fab has potential as a therapeutic mAb for treatment of anthrax.<\/jats:p>","DOI":"10.3390\/ijms151018496","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T10:28:18Z","timestamp":1413282498000},"page":"18496-18507","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preparation and Evaluation of Human-Murine Chimeric Antibody against Protective Antigen of Bacillus anthracis"],"prefix":"10.3390","volume":"15","author":[{"given":"Lina","family":"Hao","sequence":"first","affiliation":[{"name":"Huadong Medical Institute of Biotechniques, Nanjing 210002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Huadong Medical Institute of Biotechniques, Nanjing 210002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siping","family":"Xiong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Hu","sequence":"additional","affiliation":[{"name":"Huadong Medical Institute of Biotechniques, Nanjing 210002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Lv","sequence":"additional","affiliation":[{"name":"Huadong Medical Institute of Biotechniques, Nanjing 210002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Tang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqing","family":"Feng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Huadong Medical Institute of Biotechniques, Nanjing 210002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Huadong Medical Institute of Biotechniques, Nanjing 210002, China"},{"name":"Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"2","author":"Little","year":"1999","journal-title":"Microbes Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/toxins2051038","article-title":"Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin","volume":"2","author":"Lee","year":"2010","journal-title":"Toxins"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2004.07.105","article-title":"Anthrax toxin complexes: Heptameric protective antigen can bind lethal factor and edema factor simultaneously","volume":"322","author":"Pimental","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against Anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.01689-10","article-title":"Antibiotics cure anthrax in animal models","volume":"55","author":"Weiss","year":"2011","journal-title":"Anitimicrob. Agents Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.vaccine.2011.03.011","article-title":"Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacity","volume":"29","author":"Crowe","year":"2011","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/IAI.73.12.8362-8368.2005","article-title":"Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region","volume":"73","author":"Mabry","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/toxins4060430","article-title":"Monoclonal antibodies and toxins\u2014A perspective on function and isotype","volume":"4","author":"Chow","year":"2012","journal-title":"Toxins"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-695X.2011.00782.x","article-title":"Monoclonal antibodies directedagainst protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo","volume":"62","author":"Little","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/toxins3111433","article-title":"Antibodies against anthrax: Mechanisms of action and clinical applications","volume":"3","author":"Froude","year":"2011","journal-title":"Toxins"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25077","DOI":"10.1074\/jbc.M109.022061","article-title":"Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies","volume":"284","author":"Abboud","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbrc.2009.05.114","article-title":"The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody","volume":"385","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/IAI.00712-06","article-title":"Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity","volume":"74","author":"Vitale","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/iai.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/500148","article-title":"Efficient Neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen","volume":"193","author":"Chen","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and In vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jmb.2010.01.061","article-title":"Generation and characterization of a chimeric rabbit\/human Fab for co-crystallization of HIV-1 Rev","volume":"397","author":"Stahl","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pep.2003.07.005","article-title":"Purification of Fab fragments from a monoclonal antibody papain digest by gradifiow electrophoresis","volume":"32","author":"Coleman","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jmb.2008.03.045","article-title":"Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops","volume":"378","author":"Laffly","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/aps.2010.209","article-title":"Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus","volume":"32","author":"Li","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_24","unstructured":"VBASE2\u2014The Integrative Germ, Line V Gene Database. Available online:http:\/\/www.vbase2.org\/."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/10\/18496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:16:53Z","timestamp":1760217413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/10\/18496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["ijms151018496"],"URL":"https:\/\/doi.org\/10.3390\/ijms151018496","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2014,10,14]]}}}